Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen(Oslo University Hospital), Yousef Zakharia(University of Iowa Hospitals and Clinics)Clinical Cancer ResearchJune 28, 202310.1158/1078-0432.ccr-23-0416Cited by 26SaveCiteExport RISWatch citationsRelated PapersTargeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study|Oncotarget|2017|37